KarenBurnsMDMS

Pediatric Hematology & Oncology • Cincinnati, OH

Co-Director, Comprehensive Fertility Care and Preservation Program Medical Director, Cancer Survivor Center; Associate Professor, UC Department of Pediatrics

Join to view full profile

Dr. Burns is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Burns' full profile

Already have an account?

Office
3333 Burnet Ave
# ML7015
Cincinnati, OH 45229
Phone+1 513-636-4266

Fax+1 513-636-3549

Education & Training

Medical College of Wisconsin Affiliated HospitalsFellowship, Pediatric Hematology/Oncology, 2005
Tower Health/St. Christopher's Hospital for ChildrenResidency, Pediatrics, 1999 - 2002
Lewis Katz School of Medicine at Temple UniversityClass of 1999

Certifications & Licensure

OH State Medical License 2005 - 2025
WI State Medical License 2002 - 2007
PA State Medical License 2000 - 2004
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Fertility preservation in pediatric central nervous system tumors: A report from the Children's Oncology Group.
James Felker, Kari Bjornard, Allison Close, Josuah Chavez, Eric J Chow
Pediatric Blood & Cancer. 2024-11-01
Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukae...
Francis R LeBlanc, Erin H Breese, Karen C Burns, Ellen K Chang, LaQuita M Jones
British Journal of Haematology. 2024-09-01
Time to therapy and safety of testicular tissue cryopreservation in children undergoing gonadotoxic treatment or hematopoietic stem cell transplant.
Paul Campbell, Abbey Riazzi, Elizabeth Spitznagel, Marion Schulte, Olivia Frias
Journal of Pediatric Urology. 2024-08-01

Abstracts/Posters

V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute Leukemia
Karen Burns, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

I Survived Childhood Cancer. Now What?September 9th, 2022
I Survived Childhood Cancer. Now What? -News ForestAugust 20th, 2022
I Survived Childhood Cancer. Now What?August 6th, 2022